20-2417445-T-G
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 1P and 3B. PP3BP4BP6BS2_Supporting
The NM_198994.3(TGM6):c.1550T>G(p.Leu517Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000329 in 1,612,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
 Genomes: 𝑓 0.000059   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.000030   (  0   hom.  ) 
Consequence
 TGM6
NM_198994.3 missense
NM_198994.3 missense
Scores
 5
 10
 4
Clinical Significance
Conservation
 PhyloP100:  4.58  
Publications
17 publications found 
Genes affected
 TGM6  (HGNC:16255):  (transglutaminase 6) The protein encoded by this gene belongs to the transglutaminase superfamily. It catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins. Mutations in this gene are associated with spinocerebellar ataxia type 35 (SCA35). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011] 
TGM6 Gene-Disease associations (from GenCC):
- spinocerebellar ataxia type 35Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
PP3
Multiple lines of computational evidence support a deleterious effect 7: AlphaMissense, BayesDel_noAF, Cadd, MutationAssessor, PROVEAN, REVEL, REVEL [when Dann, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.27106234). 
BP6
Variant 20-2417445-T-G is Benign according to our data. Variant chr20-2417445-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 31085.
BS2
High AC in GnomAd4 at 9 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TGM6 | ENST00000202625.7 | c.1550T>G | p.Leu517Trp | missense_variant | Exon 10 of 13 | 1 | NM_198994.3 | ENSP00000202625.2 | ||
| TGM6 | ENST00000381423.1 | c.1550T>G | p.Leu517Trp | missense_variant | Exon 10 of 12 | 1 | ENSP00000370831.1 | 
Frequencies
GnomAD3 genomes  0.0000591  AC: 9AN: 152184Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
9
AN: 
152184
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000153  AC: 38AN: 248278 AF XY:  0.000149   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
38
AN: 
248278
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000301  AC: 44AN: 1460000Hom.:  0  Cov.: 33 AF XY:  0.0000289  AC XY: 21AN XY: 726356 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
44
AN: 
1460000
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
21
AN XY: 
726356
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33480
American (AMR) 
 AF: 
AC: 
0
AN: 
44722
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26130
East Asian (EAS) 
 AF: 
AC: 
40
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86228
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
51630
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5766
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
1111962
Other (OTH) 
 AF: 
AC: 
4
AN: 
60382
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.478 
Heterozygous variant carriers
 0 
 3 
 7 
 10 
 14 
 17 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 4 
 8 
 12 
 16 
 20 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000591  AC: 9AN: 152302Hom.:  0  Cov.: 32 AF XY:  0.0000806  AC XY: 6AN XY: 74482 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
9
AN: 
152302
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
6
AN XY: 
74482
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41580
American (AMR) 
 AF: 
AC: 
0
AN: 
15296
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
9
AN: 
5190
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10624
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
67992
Other (OTH) 
 AF: 
AC: 
0
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.486 
Heterozygous variant carriers
 0 
 1 
 2 
 3 
 4 
 5 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ExAC 
 AF: 
AC: 
13
ClinVar
Significance: Conflicting classifications of pathogenicity 
Submissions summary: Pathogenic:3Uncertain:1Benign:2 
Revision: criteria provided, conflicting classifications
LINK: link 
Submissions by phenotype
Spinocerebellar ataxia type 35    Pathogenic:2Uncertain:1 
Feb 28, 2019
Codex Genetics Limited
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:provider interpretation
- -
Dec 01, 2010
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
May 28, 2019
Mendelics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Acute myeloid leukemia    Pathogenic:1 
-
Fujian Institute of Hematology, Fujian Medical University
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
not specified    Benign:1 
Oct 16, 2023
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
Jun 26, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Pathogenic 
 BayesDel_addAF 
 Uncertain 
T 
 BayesDel_noAF 
 Pathogenic 
 DANN 
 Benign 
 DEOGEN2 
 Benign 
T;. 
 Eigen 
 Uncertain 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Uncertain 
D 
 LIST_S2 
 Uncertain 
D;D 
 M_CAP 
 Uncertain 
D 
 MetaRNN 
 Benign 
T;T 
 MetaSVM 
 Uncertain 
D 
 MutationAssessor 
 Pathogenic 
M;M 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Pathogenic 
D;D 
 REVEL 
 Pathogenic 
 Sift 
 Uncertain 
D;D 
 Sift4G 
 Uncertain 
D;D 
 Polyphen 
D;D 
 Vest4 
 MutPred 
Gain of catalytic residue at L515 (P = 0.0025);Gain of catalytic residue at L515 (P = 0.0025);
 MVP 
 MPC 
 ClinPred 
T 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.